Effectiveness of COVID-19 vaccine (Covaxin) against breakthrough SARS-CoV-2 infection in India-Reference-Cited by-同舟云学术

Effectiveness of COVID-19 vaccine (Covaxin) against breakthrough SARS-CoV-2 infection in India

Published:2022-01-31 Issue:1 Volume:18 Page:
ISSN:2164-5515
Container-title:Human Vaccines & Immunotherapeutics
language:en
Short-container-title:Human Vaccines & Immunotherapeutics

Author:

Behera Priyamadhaba¹^ORCID,Singh Arvind Kumar¹^ORCID,Subba Sonu Hangma¹^ORCID,Mc Arjun¹^ORCID,Sahu Dinesh Prasad¹^ORCID,Chandanshive Pradnya Dilip¹^ORCID,Pradhan Somen Kumar¹^ORCID,Parida Swayam Pragyan¹^ORCID,Mishra Abhisek¹^ORCID,Patro Binod Kumar¹^ORCID,Batmanabane Gitanjali²

Affiliation:

1. Department of Community Medicine and Family Medicine, All India Institute of Medical Sciences, Bhubaneswar, India

2. All India Institute of Medical Sciences, Bhubaneswar, India

Funder

funding

Publisher

Informa UK Limited

Subject

Pharmacology,Immunology,Immunology and Allergy

Link

https://www.tandfonline.com/doi/pdf/10.1080/21645515.2022.2034456

Reference49 articles.

1. Timeline of WHO’s response to COVID-19 [Internet]. [accessed Aug 5]. https://www.who.int/emergencies/diseases/novel-coronavirus-2019/interactive-timeline.

2. WHO Coronavirus Disease (COVID-19) Dashboard | WHO Coronavirus Disease (COVID-19) Dashboard [Internet]. [accessed 2021 Sep 20]. https://covid19.who.int/

3. COVID-19 Map - Johns Hopkins Coronavirus Resource Center [Internet]. [accessed 2021 Aug 3]. https://coronavirus.jhu.edu/map.html.

4. MoHFW | home [Internet]. Ministry of Health & Family Welfare Government of India; 2021 [accessed 2021 Dec 2]. https://www.mohfw.gov.in/.

5. Mapping First to Second wave transition of covid19 Indian data via Sigmoid function and prediction of Third wave

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. An Overview of SARS-CoV-2 Etiopathogenesis and Recent Developments in COVID-19 Vaccines;Biomolecules;2023-10-24

2. A Phase 3, randomized, non-inferiority study of a heterologous booster dose of SARS CoV-2 recombinant spike protein vaccine in adults;Scientific Reports;2023-10-03

3. Vaccination Can Prevent Severe Pulmonary Disease in COVID-19 Positive Patients: A Case-Control Study;Cureus;2023-09-20

4. Efficacy and effectiveness of inactivated vaccines against symptomatic COVID-19, severe COVID-19, and COVID-19 clinical outcomes in the general population: a systematic review and meta-analysis;The Lancet Regional Health - Western Pacific;2023-08

5. Postvaccination breakthrough SARS-CoV-2 infections among adults in Malaysia and attitudes towards future vaccination;Asian Pacific Journal of Tropical Medicine;2023-07